Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EURObservational research programme in atrial fibrillation general long-term registry.
European journal of clinical investigation, cilt.52, 2022 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 52
- Basım Tarihi: 2022
- Doi Numarası: 10.1111/eci.13773
- Dergi Adı: European journal of clinical investigation
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Agricultural & Environmental Science Database, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
- Anahtar Kelimeler: all-cause death, atrial fibrillation, cancer, malignancy, NOACs, registry, DIRECT ORAL ANTICOAGULANTS, BLEEDING COMPLICATIONS, ACTIVE CANCER, MANAGEMENT, WARFARIN, SAFETY, RISK, THROMBOEMBOLISM, GUIDELINES, EFFICACY
- Hacettepe Üniversitesi Adresli: Evet
Özet
Background: The management of patients with atrial fibrillation (AF) and malignancy is challenging given the paucity of evidence supporting their appropriate clinical management.